Early treatment discontinuation and early oxaliplatin discontinuation for stage III colorectal cancer

HIMALAYA: Study of tremelimumab and durvalumab as first-line therapy in patients with uHCC

Comparing two chemo regimen and chemoradiotherapy regimen as neoadjuvant treatment for locally advanced oesophageal cancer

Nivo + chemo vs chemo as first-line treatment for advanced GC/GEJC/EAC

OncoAlert Colloquium Day 6: Gynaecological oncology, IGCS and ESO

OncoAlert Colloquium Day 5: SWOG, OncoAlliance and more

OncoAlert Colloquium Day 4: GI oncology and EONS

OncoAlert Colloquium Day 3: Breast cancer

OncoAlert Colloquium Day 2: Lung cancer and MASCC

OncoAlert Colloquium Day 1: Genitourinary cancers and geriatric oncology

Evidence-based oncology for trainees from LMICs

The only Journey is the one within